Group items tagged

This fall, OARS will host a series of brown-bag workshops on navigating the NSF proposal process.  Workshops will be held select Tuesdays from noon to 1:00pm in Pearson 208.  You are welcome to attend any or all of the sessions.  Click through for dates and registration information.

This Funding Opportunity Announcement (FOA) will support rigorous, pre-clinical studies that establish the rationale for a clinical trial, where the hypothesis originates from use of a published or publicly available method for identifying new indications for existing drugs or biologics (therapeutics). The goal of an individual project will be to explore the potential new use of an existing investigational, phase 2a-ready, or FDA-approved drug or licensed biologic; a pre-clinical study funded through this initiative will serve as a use case to demonstrate the utility of an independent crowdsourcing effort or of a computational algorithm to predict new uses of a drug or biologic.

The intention of this Funding Opportunity Announcement is to improve the prevention, diagnosis, and treatment of vulvodynia.  By definition, vulvar discomfort or pain without a clear etiology is termed vulvodynia. Some organizations use the term vulvodynia to indicate vulvar pain of unknown etiology for more than 3 months.  For the purposes of this announcement, vulvodynia and vulvar pain will be used interchangeably.  The overall incidence of vulvodynia has been reported as 4.2 cases per 100 person-years in one population based study, with others estimating that persistent vulvar pain affects 9 to 18 percent of women at some point during their lifetime. Current evidence suggests that incidence rates vary by age, ethnicity and marital status.

The purpose of this FOA is to test a model of quality clinical care addressing childhood obesity for U.S. low-income children, especially those enrolled in or eligible for health care coverage under the Children’s Health Insurance Program (CHIP) or Medicaid. Specifically, the purpose of this FOA is to implement and test the ability of a model of clinical childhood obesity management along with a EHR-referral-based, family-centered pediatric weight management program, to reduce body mass index (BMI) in children with obesity, or overweight with risks (including, e.g., medical and behavioral risks, and family history).

The FY15/16 VRP Technology/Therapeutic Development Award (TTDA) is a mission-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including detection, diagnosis, treatment, or quality of life, in at least one of the FY15/16 VRP TTDA Capability Gaps. Products in development should be responsive to the health care needs of military Service members, Veterans, and other individuals living with visual dysfunction. 

This Funding Opportunity Announcement (FOA) encourages applications that propose to evaluate policies or large scale programs that are expected to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes have the potential to prevent or reduce rates of obesity.

Through this Addendum to the Global Development Alliance (GDA) Annual Program Statement (APS), No. APS-OAA-16-000001 (the GDA APS), USAID/Ukraine is making a special call for the submission of Concept Papers focused on stimulating innovation in the health sector through public-private alliances, and to drive broader innovation supporting more inclusive, sustainable growth in Ukraine, specifically in areas relevant to USAID's 2018-2023 Country Development Strategy.

Despite current data supporting the importance of circadian regulation of DI, molecular components that couple circadian systems with metabolic control, epigenetic modification and age-associated pathologies are not fully understood. In addition, little is known about the contributions of central clocks versus peripheral clocks for regulating circadian homeostasis in the context of aging and metabolism. Several DI modifications such as amino acid restriction, intermittent fasting, and fasting-mimicking diets have been shown to improve healthspan in animals and in human trials. Therefore, this FOA aims to examine how each of these dietary interventions entrains peripheral clocks and how circadian regulation integrates with various dietary strategies to achieve optimal health benefits.

The fellowship is a $30,000 award ($10,000 per year, for up to three years) for periodontists pursuing a career in academia. The award is not intended to replace support that would normally have been provided by the recipient's institution.

The purpose of this funding opportunity is to identify health care and clinic practices that are associated with the best outcomes for people living with spina bifida (SB) and to communicate and encourage adoption of best practices by SB clinics including providing needed educational/informational resources for the SB patient and provider communities, health care professionals, families, and educators.

The purpose of this Notice of Funding Opportunity (NOFO) is to expand the vision and eye health surveillance system by identifying and incorporating new data sources and validating data and key indicators, maintaining the existing system, and promoting the vision and eye health surveillance system to stakeholders to monitor the burden of vision loss and eye diseases and ultimately to improve the vision and eye health of the nation. Vision loss is recognized as a public health problem because it affects more than 4 million people aged 40 years and older in the United States. It is associated with higher prevalence of multiple chronic conditions such as diabetes, cardiovascular health, falls, injuries, depression, smoking, premature mortality and overall poorer quality of life. The United States government in Healthy People 2010 and 2020, in conjunction with the vision and eye care communities, have identified the reduction of population disparities in vision loss and access to eye care services as top public health priorities. Despite the knowledge about the individual and societal burden of vision loss and eye diseases, the public health surveillance system in the United States has only just begun to systematically understand and monitor the magnitude and implications of vision loss, access to eye care, and effectiveness of services that potentially improve health and quality of life of those who are at risk of or experience vision loss.

The purpose of this Funding Opportunity Announcement (FOA) is to facilitate the design, conduct, and completion of clinical trials for improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals. To serve this goal, the FOA will support a network of international collaborative sites conducting meritorious and appropriately designed prevention clinical trials in the Latin American and Caribbean (LAC) region via a U54 Partnership Centers mechanism.

The purpose of this funding opportunity announcement (FOA) is twofold: (1) to stimulate basic and mechanistic science that facilitates the development of effective probiotics or pre-/probiotic combinations of relevance to human health and disease; and (2) determine biological outcomes for the evaluation of efficacy of pre/probiotics in appropriate test systems and animal models. This FOA encourages basic and mechanistic studies using in vitro, in vivo, ex vivo, and in silico models that focus on prebiotic/probiotic strain selectivity, interaction, and function. It will also encourage inter and multidisciplinary collaborations among scientists in a wide range of disciplines including nutritional science, immunology, microbiomics, genomics, other '-omic' sciences, biotechnology, and bioinformatics.

The FY18 PH/TBIRP CTRR-CTA is intended to support clinical trials focused on TBI cognitive rehabilitation interventions. The award mechanism supports small, Phase I clinical trials to advance the development of knowledge and materiel products for rehabilitation and restoration of function following TBI in Service members, Veterans, and other individuals.

The intent of this Program Announcement is to evaluate the efficacy of evidence-based methods and strategies for rapidly enhancing leader effectiveness, individual and small team performance, and resilience to stressors. Applications that examine the effectiveness of approaches that translate and integrate content into the everyday routines of SMs, first responders, and small teams to enhance psychological health readiness are encouraged. While additional intervention techniques are being sought as part of this award, the goal is not to overload individuals, units, and leaders with new training. Instead, the goal is to ensure that any training that is offered is engaging and proven to be effective. In addition, the intervention does not necessarily have to be training-based. Strategies that include non-intrusive methods are of interest if they improve the health and functioning of individuals, teams, and/or leaders.

The purpose of this funding opportunity announcement (FOA) is to encourage modular budget R01 grant applications from nurse scientists who are currently or were recently supported by an NIH Career Development (K) award. This opportunity is limited to those K awardee nurse scientists who have not yet earned an R01 equivalent award. Through this opportunity, NINR seeks to enhance the transition of nurse scientists to independent investigator status.

This R18 Request for Application (RFA) calls for the creation and utilization of Patient Safety Learning Laboratories.  These learning laboratories are places and networks where transdisciplinary teams identify closely related threats to diagnostic or treatment efforts associated with a high burden of harm and cost. Following a systems engineering methodology, the learning laboratories stretch professional boundaries, envision innovative designs, and take advantage of brainstorming and rapid prototyping techniques that other leading industries employ.  Promising prototypes undergo further develop-test-revise iterations, and subsequent integration as a working system. After further improvements are made to the integrated working system, its efficacy is evaluated in a realistic simulated or clinical setting.

The purpose of this funding opportunity announcement (FOA) is to promote initial establishment of basic science-clinical collaborations by providing small grants to teams of basic scientists, physician scientists, and/or clinicians. These interdisciplinary teams may include but are not limited to the following: developmental biologists, cell biologists, geneticists, genomicists, physician scientists including individuals with DVM/VMD degrees, clinicians, epidemiologists, biostatisticians, and/or bioinformaticists.

The Adolescent Brain Cognitive Development (ABCD) Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old repeatedly for 10 years and makes that data available to the scientific community through the NIMH Data Archive. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. More information about the ABCD Study may be found on the ABCD Study web page (www.abcdstudy.org).

The purpose of this Funding Opportunity Announcement (FOA) is to develop and test strategies to increase the engagement of men in HIV prevention and care within global settings and among US domestic populations who have evidenced lower rates of engagement and retention in HIV prevention and care. The R01 mechanism is intended to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies.